Comparison of Hemodynamic Variables Between Using Conventional Invasive Catheter Monitoring and Non-invasive Piezoelectric Sensor
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Arterial pressure is obtained from invasive arterial monitoring and noninvasive arterial monitoring using piezoelectric sensor and compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedStudy Start
First participant enrolled
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 18, 2026
August 7, 2025
July 1, 2025
1.3 years
July 31, 2025
July 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Arterial pressure
After the induction of anesthesia, 20G catheter is placed for invasive arterial pressure monitoring in the radial artery and pressure sensor is attached for noninvasive arterial pressure monitoring in the contralateral radial artery. Then, invasive and noninvasive arterial pressures are monitored and obtained simultaneously.
For 30 min after the induction of anesthesia,
Study Arms (2)
Invasive group
ACTIVE COMPARATORArterial pressure is obtained from invasive arterial monitoring
Noninvasive arterial monitoring
EXPERIMENTALArterial pressure is obtained from non-invasive arterial monitoring
Interventions
Arterial pressure is monitored and obtained
Eligibility Criteria
You may qualify if:
- Cases who require Invasive arterial pressure monitoring d/t bleeding.
You may not qualify if:
- Patients with cardiovascular disease, cerebrovascular diseases, renal disease, or Marfan syndrome
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 7, 2025
Study Start
August 22, 2025
Primary Completion (Estimated)
December 18, 2026
Study Completion (Estimated)
December 18, 2026
Last Updated
August 7, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share